COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (BETAMI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03646357
Recruitment Status : Recruiting
First Posted : August 24, 2018
Last Update Posted : October 2, 2018
Drammen sykehus
The Hospital of Vestfold
University of Oslo
Helse Stavanger HF
Haukeland University Hospital
St. Olavs Hospital
University Hospital of North Norway
Sorlandet Hospital HF
Information provided by (Responsible Party):
Dan Atar, Oslo University Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2022
Estimated Study Completion Date : October 1, 2023